Stoke Therapeutics, Inc. (STOK)

32.70 -0.58 (-1.74%) USD  |  NASDAQ  |  May 07, 10:58
More

Stoke Therapeutics SG&A Expense (TTM) : 67.09M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biogen, Inc. 2.468B
Krystal Biotech, Inc. 114.19M
Scholar Rock Holding Corp. 176.20M
Vertex Pharmaceuticals, Inc. 1.357B
Zymeworks, Inc. 61.51M